Hematologic Malignancies Therapeutics Market: Research Insights and...

أضاف وظيفة جديدة أخرى

2026-10-26 13:42:31 -

Hematologic Malignancies Therapeutics Market: Research Insights and Emerging Treatment Options

Valued at USD 71.38 billion in 2024, the hematologic malignancies therapeutics market is projected to reach USD 76.63 billion in 2025 and USD 148.15 billion by 2034, growing at a CAGR of 7.6% during the forecast period 2025–2034. North America held the largest regional position in 2024. Key players include AbbVie Inc., Amgen Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd.,...

0 التعليقات 0 المشاركات 4 مشاهدة 0 معاينة